Be it enacted by the General Assembly of Virginia:
1. §1. That the Board of Medicine shall develop a patient decision checklist for patients considering breast implants. Such checklist shall comply with U.S. Food and Drug Administration requirements for checklists distributed by breast implant manufacturers. Such checklist shall include information on the risks of potential complications from breast implants, potential development of breast implant-associated anaplastic large cell lymphoma, increased chance of development of certain autoimmune and connective tissue diseases, and other systemic symptoms associated with breast implants. It shall also include information about aesthetic flat closure as an alternative to breast implants.